Skip to main content
Premium Trial:

Request an Annual Quote

Peer-Reviewed Freebie Makes its Debut

NEW YORK, June 18 - BioMed Central today announced the publication of its free-access peer-reviewed Journal of Biology.


Articles accepted for publication--which BioMed contends will be peer-reviewed and on a par with those found in Science, Nature, and Cell--will appear online within two weeks and be published in a print version soon thereafter.


The journal is open to "the full spectrum of biology" so long as articles are "appropriate for consideration," according to the new journal's web site. So far the Journal has one article: 'Evidence for large domains of similarly expressed genes in the Drosophila genome.'


The homepage currently contains the one article; a commentary by Peter Suber of Earlham College, in Indiana; and a maiden editorial by Editor-in-Chief Martin Raff, Editor Theodora Bloom, and BioMed Central Editorial Director Peter Newmark.


According to the editorial, the Journal of Biology, based in London, differs from traditional peer-reviewed journals in two ways: There are no subscription fees and authors retain copyright of their papers.

GenomeWeb first reported last year on the idea behind the novel journal.


"These are the principles of open access publishing, to which Journal of Biology ...  are committed," the editors write.


The advantages of so-called open-access publishing "are especially great for papers of exceptionally broad interest, as anyone with an interest in the research can access it without hindrance anywhere and at any time," the editorial continues. Consequently, "authors and their funders can distribute their article as they wish, ensuring maximum dissemination of their work."


It was not immediately clear what the source of revenues for the Journal are, though there is information on the web site for potential advertisers, and a couple of ads are currently seen at the foot of most pages.


Click here to visit the Journal of Biology.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.